128 related articles for article (PubMed ID: 8372452)
1. HIV-1 latency due to the site of proviral integration.
Winslow BJ; Pomerantz RJ; Bagasra O; Trono D
Virology; 1993 Oct; 196(2):849-54. PubMed ID: 8372452
[TBL] [Abstract][Full Text] [Related]
2. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
3. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
4. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
[TBL] [Abstract][Full Text] [Related]
5. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.
Chen BK; Saksela K; Andino R; Baltimore D
J Virol; 1994 Feb; 68(2):654-60. PubMed ID: 7507183
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of high-titer stocks of rev-defective HIV-1.
Riggs NL; Guatelli JC
Virology; 1996 Mar; 217(2):602-6. PubMed ID: 8610453
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.
Shirazi Y; Pitha PM
Virology; 1993 Mar; 193(1):303-12. PubMed ID: 8438572
[TBL] [Abstract][Full Text] [Related]
9. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
10. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
11. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
13. Rapid and sensitive detection of cell-associated HIV-1 in latently infected cell lines and in patient cells using sodium-n-butyrate induction and RT-PCR.
Kashanchi F; Melpolder JC; Epstein JS; Sadaie MR
J Med Virol; 1997 Jun; 52(2):179-89. PubMed ID: 9179766
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
15. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
17. Homologous superinfection of both producer and nonproducer HIV-infected cells is blocked at a late retrotranscription step.
Taddeo B; Federico M; Titti F; Rossi GB; Verani P
Virology; 1993 Jun; 194(2):441-52. PubMed ID: 8503167
[TBL] [Abstract][Full Text] [Related]
18. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity.
Nahreini P; Mathews MB
Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945
[TBL] [Abstract][Full Text] [Related]
19. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
